Pre-specified exploratory objectives included an analysis of the relationship between co-occurring mutations, rate of IDH2 mutation clearance by NGS, the incidence of MRD-negativity by flow cytometry, and the incidence and characteristics of IDHi-associated differentiation syndrome (IDH-DS) with combination therapy. The gene discussed is IDH2; the disease is Dravet syndrome.